Anteris Technologies Global Corp.
General ticker "AVR" information:
- Sector: Health Care
- Industry: Medical - Devices
- Capitalization: $144.1M (TTM average)
Anteris Technologies Global Corp. follows the US Stock Market performance with the rate: 54.6%.
Estimated limits based on current volatility of 4.0%: low 7.00$, high 7.59$
Factors to consider:
- Total employees count: 174 (+27.9%) as of 2025
- Top business risk factors: Operating losses, Product development failure, Strategic risks and growth management, Market acceptance, Regulatory and compliance
- Earnings for 6 months up through Q2 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-12-31 to 2027-12-31
- 2025-12-31 to 2026-12-31 estimated range: [2.92$, 7.88$]
- 2026-12-31 to 2027-12-31 estimated range: [2.31$, 6.45$]
Short-term AVR quotes
Long-term AVR plot with estimates
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | $2.73MM | $2.70MM | $1.91MM |
| Operating Expenses | $50.87MM | $81.08MM | $95.81MM |
| Operating Income | $-48.14MM | $-78.37MM | $-93.89MM |
| Non-Operating Income | $1.38MM | $2.40MM | $-0.33MM |
| Interest Expense | $0.07MM | $0.05MM | $0.07MM |
| R&D Expense | $31.02MM | $51.45MM | $69.12MM |
| Income(Loss) | $-46.76MM | $-75.97MM | $-94.22MM |
| Net Income(Loss)* | $-46.02MM | $-76.29MM | $-94.14MM |
| Stockholders Equity | $19.30MM | $62.76MM | $-0.09MM |
| Inventory | $0.44MM | $0.51MM | $0.73MM |
| Assets | $30.53MM | $80.70MM | $23.00MM |
| Operating Cash Flow | $-34.63MM | $-61.24MM | $-77.80MM |
| Capital expenditure | $2.39MM | $2.27MM | $1.95MM |
| Investing Cash Flow | $-2.58MM | $-2.28MM | $-0.60MM |
| Financing Cash Flow | $49.34MM | $112.83MM | $20.55MM |
| Earnings Per Share** | $-1.28 | $-3.77 | $-2.55 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.